ONCOLYTICS BIOTECH INC

ONCY · Nasdaq · SIC 2834: Pharmaceutical Preparations
853
SEC Filings

Business Summary

PART I Company Overview We are a clinical-stage biopharmaceutical company developing pelareorep, a well-tolerated intravenously delivered immunotherapeutic agent that selectively replicates in RAS-mutated tumors and activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. Pelareorep is a proprietary isolate of reovirus, a naturally ...

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionONCYdiscussed_in_filing Cybersecurity
topic_mentionONCYdiscussed_in_filing Trusted Computing
topic_mentionONCYdiscussed_in_filing Blockchain & Crypto
topic_mentionONCYdiscussed_in_filing Regulation
topic_mentionONCYdiscussed_in_filing Healthcare & Bio
topic_mentionONCYdiscussed_in_filing Platform & Ecosystem
topic_mentionONCYdiscussed_in_filing Sovereign & Government
topic_mentionONCYdiscussed_in_filing Cybersecurity
topic_mentionONCYdiscussed_in_filing Trusted Computing
topic_mentionONCYdiscussed_in_filing Blockchain & Crypto
topic_mentionONCYdiscussed_in_filing Regulation
topic_mentionONCYdiscussed_in_filing Healthcare & Bio
topic_mentionONCYdiscussed_in_filing Platform & Ecosystem
topic_mentionONCYdiscussed_in_filing Sovereign & Government
topic_mentionONCYdiscussed_in_filing Cybersecurity
topic_mentionONCYdiscussed_in_filing Trusted Computing
topic_mentionONCYdiscussed_in_filing Blockchain & Crypto
topic_mentionONCYdiscussed_in_filing Regulation
topic_mentionONCYdiscussed_in_filing Healthcare & Bio
topic_mentionONCYdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-302025-12-310001129928-26-000020EDGAR65K words

Quarterly Reports (10-Q)

No 10-Q filings indexed.

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-060001104659-26-039935EDGAR22K words
2026-04-060001129928-26-000024EDGAR—
2026-04-010001104659-26-038272EDGAR—
2026-03-200001104659-26-032763EDGAR—
2026-03-190001129928-26-000011EDGAR—
2026-03-020001129928-26-000009EDGAR—
2026-02-240001129928-26-000006EDGAR—
2026-02-040001129928-26-000004EDGAR—
2026-01-150001104659-26-004103EDGAR—
2026-01-150001104659-26-003815EDGAR—

853 total filings indexed. 842 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001129928
TickerONCY
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 92bada1f2ba9b6d937677752f741a5b7d8630cfc72e09317542f399c29782b0c
parent: 88b06152240d430dda9c9735661badc4af36f5363719b179001f2200447042ab
content hash: e06266e57b8aacb1cf93214d52df78998cc3221e90dc7818aaed08e01a65bf04
signed: 2026-04-13T04:46:43.596Z
sources: 1 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf